Attenuation of neomycin ototoxicity by iron chelation

Laryngoscope

Volumn 108, Issue 2, 1998, Pages 284-287

  Conlon, Brendan J ^a   Perry, Brian P ^a   Smith, David W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CHELATING AGENT; DEFEROXAMINE; HYDROXYL RADICAL; NEOMYCIN;

ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG INDUCED DISEASE; GUINEA PIG; HAIR CELL; HEARING LOSS; INNER EAR DISEASE; INTRAMUSCULAR DRUG ADMINISTRATION; IRON CHELATION; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; AUDITORY THRESHOLD; DEFEROXAMINE; EVOKED POTENTIALS, AUDITORY; FREE RADICALS; GUINEA PIGS; HEARING DISORDERS; IRON CHELATING AGENTS; NEOMYCIN;

EID: 0031883495     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199802000-00023     Document Type: Article

References (28)

1. Hindshaw HC, Feldman WH. Streptomycin in treatment of clinical tuberculosis: a preliminary report. Proc Staff Meetings Mayo Clin 1945;20:313-318.
2. Molitar H, Kuna S. Pharmacologic study of the neurotoxic properties of commercial streptomycin. Arch Int Pharmacodyn Ther 1949;78:197-202.
3. Caussé R, Gondet I, Vallancien B. Action vestibulaire de la streptomycine chez la souris. C R Soc Biol (Paris) 1948;142; 747-52.
4. Hawkins JE, Jr, Engström H. The effect of kankamycin on cochlear cytoarchitecture. Acta Otolaryngol Stockh (Suppl) 1964;188:100-6.
5. Kohonen A. Effect of ototoxic drugs upon the pattern and innervation of cochlear sensory cells in the guinea pig. Acta Otolaryngol Stockh (Suppl) 1965;208:9-67.
6. Stebbins WC, Miller JM, Johnson JM, Hawkins JE Jr. Ototoxic hearing loss and cochlear pathology in the monkey. Ann Otol Rhinol Laryngol 1969;78:1007-25.
7. Garetz SL, Altschuler, Schacht J. Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo. Hearing Res 1994;77:81-7.
8. Song BB, Schacht J. Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hearing Res 1996;94:87-93.
9. Pierson MG, Møller AR. Prophylaxis of kanamycin induced ototoxicity by a radioprotectant. Hearing Res 1981;4: 79-87.
10. Clerici WJ, Hensley K, DiMartino DL, Butterfield DA. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hearing Res 1996;98: 116-124
11. Priuska EA, Schacht J. Formation of free radicals by gentamicin and iron and evidence for an iron /gentamicin complex. Biochem Pharmacol 1995;50:1749-1752.
12. Smith DW, Finley CC, van den Honert C, Olszyk VB, Konrad KEM. "Behavioral and electro physiological responses to electrical stimulation in the cat. I. Absolute thresholds," Hearing Res 1994;81:1-10.
13. Whelton A. Therapeutic initiatives for the avoidance of aminoglycoside toxicity. J Clin Pharmacol 1985;25:67-81.
14. Shafer RW, Chirgwin KD, Glatt AE, Dahdouh MA. Landesman SH, Suster B. HIV prevalence, immunosuppression and drug resistance in patients with tuberculosis in an area endemic for aids. AIDS 1991;5:399-405.
15. Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, McDonald WJ. High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J Infect Dis 1992;165:1026-1032.
16. Halliwell B, Gutteridge. Role of iron in oxygen radical reactions. Methods in Enzymology 1984;105:47-56.
17. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-1623
18. Kays SE, Crowell WA, Johnson MA. Iron supplementation increases gentamicin nephrotoxicity in rats. J Nutr 1992; 121:1869-1875
19. Ben Ismail TH, Ali BH, Bashir AA. Influence of iron, deferoxamine and ascorbic acid on gentamicin-induced nephrotoxicity in rats. Gen Pharmacol 1994;25:1249-1252
20. Brummett RE, Harris RF, Lindgren JA. Detection of ototoxicity from drugs applied topically to the middle ear space. Laryngoscope 1976;86:1177-1187
21. Kohonen A, Tarkkanen J. Cochlear damage from ototoxic antibiotics by intratympanic application. Acta Otolaryngol (Stockh) 1969;68:90-97
22. Effect of cortisporin otic suspension on cochlear function and efferent activity in the guinea pig. Laryngoscope 1996;106: 1557-1561.
23. Barratt PS, Toogood IRG. Hearing loss attributed to desferrioxamine in patients with beta-thalassemia major. Med J Aust 1987;147:177-179.
24. Hazell JVP, Modell CB. ENT complications in thalassemia major. J Laryngol Otol 1976;90:877-881.
25. Porter JB, Huehns ER. The toxic effects of desferrioxamine. Clin Haematol 1989;2:459-474.
26. Kanno H. Yamanobe S, Rybak LP. The ototoxicity of deferoxamine mesylate. Am J Otolaryngol 1995;16:148-152.
27. Shirane M, Harrison RV. The effect of deferoxamine mesylate and hypoxia on the cochlea. Acta Otolarngol (Stockh) 1987; 104:99-107.
28. Shirane M, Harrison RV. A study of the ototoxicity of deferoxamine in the chinchilla. J Otolaryngol 1987;16:334-339.